Alterity Therapeutics Announces Publication Demonstrating the Utility of Quantitative MRI as a Biomarker for Multiple System Atrophy

Go back to Alterity Therapeutics Announces Publication Demonstrating the Utility of Quantitative MRI as a Biomarker for Multiple System Atrophy
(NYSE: ATH) Delayed: 83.33 --0 (-0%)
Previous Close $83.33    52 Week High
Open $83.33    52 Week Low
Day High $83.33    P/E N/A 
Day Low $83.33    EPS
Volume 7,858       

(NASDAQ: ATHE) Delayed: 4.93 --0 (-0%)
Previous Close $4.93    52 Week High
Open $4.93    52 Week Low
Day High $4.93    P/E N/A 
Day Low $4.93    EPS
Volume 56